Tom Evers
PostDoc
- Naam
- Dr. T.M.J. Evers
- Telefoon
- +31 71 527 6231
- t.m.j.evers@lacdr.leidenuniv.nl
- ORCID iD
- 0000-0003-2678-2971
PostDoc
- Wiskunde en Natuurwetenschappen
- Leiden Academic Centre for Drug Research
- LACDR/Pharmacology
- Evers T.M.J. (26 maart 2024), Single cell mechanics for disease biology and pharmacology (Dissertatie. Leiden Academic Centre for Drug Research (LACDR), Faculty of Science, Leiden University). Promotor(en): Mashaghi Tabari A. & Lange E.C.M. de.
- Babaei M., Evers T.M.J., Gaudio N. Del., Altucci L. & Mashaghi A. (2024), Design principles and control of non-cooperative oscillatory enzymatic reactions, Chemical Engineering Science 293: 120040.
- Lith S.C., Evers T.M.J., Freire B.M. Tiel C.M. van, Vos W.G., Mashaghi A. & Vries C.J.M. de (2024), Nuclear receptor Nur77 regulates immunomechanics of macrophages, European Journal of Cell Biology 103(2): 151419.
- Evers T. M.J., Babaei M. & Mashaghi A. (2024), Probing human immune cell mechanics using acoustic force spectroscopy, Leiden Academic Centre for Drug Research, Faculty of Mathematics and Natural Sciences, Leiden University. Leiden. [5].
- Evers T.M.J., Weverwijk A. van, Visser K.E. de & Mashaghi A. (2024), Single-cell analysis of innate immune cell mechanics: an application to cancer immunology, Materials Advances 5(12): 5025-5035.
- Babaei M., Evers T.M.J., Shokri F., Altucci L., Lange E.C.M. de & Mashaghi Tabari A. (2023), Biochemical reaction network topology defines dose-dependent drug-drug interactions, Computers in Biology and Medicine 155: 106584.
- Evers T.M.J., Sheikhhassani V., Tang H., Haks M.C., Ottenhoff T.H.M. & Mashaghi A. (2022), Single‐cell mechanical characterization of human macrophages, Advanced NanoBiomed Research 2(7): 2100133.
- Chianese U., Papulino C., Passaro E., Evers T.M.J., Babaei M., Toraldo A., Marchi T. de, Niméus E., Carafa V., Nicoletti M.M., Gaudio N. del, Iaccarino N., Randazzo A., Rotili D., Mai A., Cappabianca S., Mashaghi Tabari A., Ciardiello F., Altucci L. & Benedetti R. (2022), Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics, Molecular Metabolism 64: 101561.